HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device

HER2-targeted therapy influences CTC status in metastatic breast cancer

(2020) Thomas M. Deutsch et al.   BREAST CANCER RESEARCH AND TREATMENT

Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips

(2019) Arutha Kulasinghe et al.   Cancers

Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel

(2019) Jian Zhou et al.   Microsystems & Nanoengineering

The Significance of Circulating Tumour Cells in the Clinic

(2019) Sara Abalde-Cela et al.   ACTA CYTOLOGICA

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients

(2019) Silvina Ribeiro-Samy et al.   Scientific Reports

Isolation of cells from whole blood using shear-induced diffusion

(2018) Jian Zhou et al.   Scientific Reports

Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: a novel biomarker and an analytical tool for precision oncology applications

(2018) Manuel Neves et al.   New Biotechnology

Characterization of circulating tumor cells in breast cancer patients by spiral microfluidics

(2018) Jianhua Yin et al.   CELL BIOLOGY AND TOXICOLOGY

Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer

(2018) Weirong Chen et al.   Clinical Breast Cancer

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

(2018) Massimo Cristofanilli et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Integrating liquid biopsies into the management of cancer

(2017) Giulia Siravegna et al.   Nature Reviews Clinical Oncology

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases

(2017) Luís Lima et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The dawn of the liquid biopsy in the fight against cancer

(2017) Irma G. Domínguez-Vigil et al.   Oncotarget

Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

(2017) Xiaofeng Dai et al.   Journal of Cancer

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells

(2017) Eric Lin et al.   Cell Systems

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine

(2017) Cory M. Hugen et al.   Frontiers in Oncology

Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

(2016) Dharanija Madhavan et al.   CARCINOGENESIS

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial

(2016) Michail Ignatiadis et al.   EUROPEAN JOURNAL OF CANCER

Circulating tumor cells in breast cancer

(2016) Francois-Clement Bidard et al.   Molecular Oncology

Emerging therapeutic targets in metastatic progression: A focus on breast cancer

(2016) Zhuo Li et al.   PHARMACOLOGY & THERAPEUTICS

A headlight on liquid biopsies: a challenging tool for breast cancer management

(2016) Daniela Massihnia et al.   TUMOR BIOLOGY

Pathologists and liquid biopsies: to be or not to be?

(2016) Paul Hofman et al.   VIRCHOWS ARCHIV

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

(2016) C. Alix-Panabieres et al.   Cancer Discovery

Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology

(2016) James Che et al.   Oncotarget

World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015

(2016) Shelley McGuire   Advances in Nutrition

Efficient microfluidic negative enrichment of circulating tumor cells in blood using roughened PDMS

(2015) L. Diéguez et al.   ANALYST

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

(2015) Hara Polioudaki et al.   BMC CANCER

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Triple-negative breast cancer

(2015) Sara Hurvitz et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Challenges in circulating tumor cell detection by the CellSearch system

(2015) Kiki C. Andree et al.   Molecular Oncology

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer

(2015) Bernadette A.S. Jäger et al.   Translational Oncology

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

(2015) Louis P. Garrison et al.   VALUE IN HEALTH

Deformability of Tumor Cells versus Blood Cells

(2015) Josephine Shaw Bagnall et al.   Scientific Reports

Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System

(2015) Lei Xu et al.   PLoS One

Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2+ Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERLY-2 Survival Data

(2014) J.-Y. Pierga et al.   CLINICAL CANCER RESEARCH

Updated UK Recommendations for HER2 assessment in breast cancer

(2014) Emad A Rakha et al.   JOURNAL OF CLINICAL PATHOLOGY

Detection and isolation of circulating tumor cells: Principles and methods

(2013) Hadi Esmaeilsabzali et al.   BIOTECHNOLOGY ADVANCES

Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer

(2013) Anna S. Berghoff et al.   Breast Journal

Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients

(2013) Yibin Kang et al.   CANCER CELL

Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?

(2013) K. Pantel et al.   CANCER RESEARCH

Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

(2013) Julien Mazières et al.   JOURNAL OF CLINICAL ONCOLOGY

Fundamentals of inertial focusing in microchannels

(2013) Jian Zhou et al.   LAB ON A CHIP

Advances and critical concerns with the microfluidic enrichments of circulating tumor cells

(2013) Kyung-A Hyun et al.   LAB ON A CHIP

Size-selective collection of circulating tumor cells using Vortex technology

(2013) Elodie Sollier et al.   LAB ON A CHIP

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

(2013) M. Yu et al.   SCIENCE

Isolation and retrieval of circulating tumor cells using centrifugal forces

(2013) Han Wei Hou et al.   Scientific Reports

Circulating Tumor Cells: Liquid Biopsy of Cancer

(2012) C. Alix-Panabieres et al.   CLINICAL CHEMISTRY

Microfluidics and Circulating Tumor Cells

(2012) Yi Dong et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

(2012) Christina Curtis et al.   NATURE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Breast cancer genome-wide association studies: there is strength in numbers

(2011) D Fanale et al.   ONCOGENE

HER2-Positive Circulating Tumor Cells in Breast Cancer

(2011) Michail Ignatiadis et al.   PLoS One

Microfluidic Devices for Blood Fractionation

(2011) Han Wei Hou et al.   Micromachines

Herceptin functionalized microfluidic polydimethylsiloxane devices for the capture of human epidermal growth factor receptor 2 positive circulating breast cancer cells

(2010) Benjamin Thierry et al.   Biomicrofluidics

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

(2010) S. Riethdorf et al.   CLINICAL CANCER RESEARCH

The molecular pathology of breast cancer progression

(2010) Alessandro Bombonati et al.   JOURNAL OF PATHOLOGY

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

(2010) Britta Weigelt et al.   LANCET ONCOLOGY

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

(2010) Sunil Badve et al.   MODERN PATHOLOGY

Histological types of breast cancer: How special are they?

(2010) Britta Weigelt et al.   Molecular Oncology

Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

(2010) A.-E. Saliba et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification

(2009) Pamela Klingbeil et al.   BREAST CANCER RESEARCH AND TREATMENT

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

(2009) I Van der Auwera et al.   BRITISH JOURNAL OF CANCER

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

(2009) Britta Weigelt et al.   JOURNAL OF PATHOLOGY

Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer

(2008) Jeffrey Peppercorn et al.   CANCER INVESTIGATION